Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Total 13F shares
-
41,627,417
-
Share change
-
+2,085,317
-
Total reported value
-
$2,926,846,973
-
Put/Call ratio
-
100%
-
Price per share
-
$70.31
-
Number of holders
-
172
-
Value change
-
+$146,410,374
-
Number of buys
-
81
-
Number of sells
-
78
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q4 2016
As of 31 Dec 2016 Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) had 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 41,627,417 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, VANGUARD GROUP INC, BlackRock Fund Advisors, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, COLUMBIA WANGER ASSET MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., and Capital International Investors.
This table shows 172 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.